Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next month Japan’s largest drugmaker overhauls its business to cut costs and embrace new technologies to boost efficiency and growth.
Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next month Japan’s largest drugmaker overhauls its business to cut costs and embrace new technologies to boost efficienc… [268 chars]
Source: Bloomberg | Published: 2026-03-25T09:34:03Z
Credit: Bloomberg
